Next Article in Journal / Special Issue
Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy
Previous Article in Journal
Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk Assessment
Previous Article in Special Issue
Oncolytic Adenoviruses in Cancer Treatment
 
 
Article

Article Versions Notes

Biomedicines 2014, 2(1), 98-109; https://doi.org/10.3390/biomedicines2010098
Action Date Notes Link
article pdf uploaded. 5 March 2014 09:07 CET Version of Record -
article pdf uploaded. 6 March 2014 08:15 CET Updated version of record https://www.mdpi.com/2227-9059/2/1/98/pdf
article html file updated 19 August 2015 22:36 CEST Original file -
article html file updated 23 February 2017 02:21 CET Update -
article html file updated 21 March 2019 13:22 CET Update -
article html file updated 7 May 2019 17:46 CEST Update -
article html file updated 6 February 2020 07:41 CET Update https://www.mdpi.com/2227-9059/2/1/98/html
Back to TopTop